Study design (if review, criteria of inclusion for studies)
Randomized Cross-Over Trial
Participants
Patients with Cystic Fibrosis (pwCF) and Primary Ciliary Dyskinesia (pwPCD). 47 clinically stable outpatients (36 pwCF, 11 pwPCD; 16.7â±â8.1 years)
Interventions
Each patient underwent N(2)MBW and spirometry at two consecutive visits (median interval 104 days): Group I: Spirometry followed by N(2)MBW (A), reversed order at the second visit (B), Group II reversed (BâA).
Outcome measures
z-score FEV1
Main results
There was a significant deterioration in z-score FEV1 between the two appointments (period effect: -0.177; pâ=â0.012). The intervention effect and 95% confidence interval were within the equivalence range in both groups (z-score FEV1: 0.039; -0.0765 to 0.1539, LCI(2.5): -0.082; -0.3691 to 0.2054).
Authors' conclusions
AB - BACKGROUND: When monitoring lung function in patients with Cystic Fibrosis (pwCF) and Primary Ciliary Dyskinesia (pwPCD), nitrogen multiple breath washout (N(2)MBW) is usually performed before spirometry to prevent forced expiratory maneuvers from altering N(2)MBW results. The N(2)MBW may affect spirometry if cooperation decreases after a long period of examination or due to prolonged oxygen inhalation. The equivalence of these concepts has never been investigated in a randomized cross-over trial. We hypothesized that the order of pulmonary function tests (PFTs) would not influence the z-score FEV(1). METHODS: A total of 47 clinically stable outpatients (36 pwCF, 11 pwPCD; 16.7â±â8.1 years) were randomized into two groups. Each patient underwent N(2)MBW and spirometry at two consecutive visits (median interval 104 days): Group I: Spirometry followed by N(2)MBW (A), reversed order at the second visit (B), Group II reversed (BâA). STATISTICS: For the equivalence test, a change in z-score FEV1 (primary endpoint) ±0.2 and lung clearance index (LCI(2.5), secondary endpoint) ±15% was not considered relevant; therefore, changes outside this range were considered an intervention effect in the linear mixed model (pâ<â0.05). RESULTS: There was a significant deterioration in z-score FEV1 between the two appointments (period effect: -0.177; pâ=â0.012). The intervention effect and 95% confidence interval were within the equivalence range in both groups (z-score FEV1: 0.039; -0.0765 to 0.1539, LCI(2.5): -0.082; -0.3691 to 0.2054). DISCUSSION: In our cohort the order of PFTs has no influence on the results suggesting that a greater flexibility in practice is possible without the risk of falsifying results. TRIAL REGISTRATION: German Clinical Trials Register (No. DRKS00027473).